194 related articles for article (PubMed ID: 17571476)
1. Cryoglobulinaemia and autoimmune markers in hepatitis C virus infected patients on renal replacement therapy.
Anis S; Muzaffar R; Ahmed E; Ali S; Nadir A; Naqvi A; Rizvi AH
J Pak Med Assoc; 2007 May; 57(5):225-9. PubMed ID: 17571476
[TBL] [Abstract][Full Text] [Related]
2. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
5. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
Batchoun RG; Al-Najdawi MA; Al-Taamary S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
[TBL] [Abstract][Full Text] [Related]
6. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
7. Relationship of HLA antigens and cryoglobulinaemia in hepatitis C virus infected patients.
Anis S; Muzaffar R; Zafar MN; Ahmed E; Fatima K; Naqvi SA; Rizvi SA
J Pak Med Assoc; 2007 Jun; 57(6):300-5. PubMed ID: 17629232
[TBL] [Abstract][Full Text] [Related]
8. Cryoglobulinaemia among maintenance haemodialysis patients and its relation to hepatitis C infection.
Okuda K; Yokosuka O; Otake Y; Hayashi H; Yokozeki K; Kashima T; Kobayashi S; Sakuma K; Ohni T; Irie Y
J Gastroenterol Hepatol; 1998 Mar; 13(3):248-52. PubMed ID: 9570236
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
10. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
11. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q antibodies in hepatitis C virus infection.
Saadoun D; Sadallah S; Trendelenburg M; Limal N; Sene D; Piette JC; Schifferli JA; Cacoub P
Clin Exp Immunol; 2006 Aug; 145(2):308-12. PubMed ID: 16879251
[TBL] [Abstract][Full Text] [Related]
13. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
[TBL] [Abstract][Full Text] [Related]
14. Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.
Fadda SH; Bassyouni IH; Hamdy A; Foad NA; Wali IE
Immunol Invest; 2015; 44(1):45-55. PubMed ID: 25028787
[TBL] [Abstract][Full Text] [Related]
15. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection.
Wong VS; Egner W; Elsey T; Brown D; Alexander GJ
Clin Exp Immunol; 1996 Apr; 104(1):25-31. PubMed ID: 8603528
[TBL] [Abstract][Full Text] [Related]
16. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
[TBL] [Abstract][Full Text] [Related]
17. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
Sasso EH
Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.
Kirdar S; Sener AG; Cengİz M; Aydin N
APMIS; 2016 Nov; 124(11):979-984. PubMed ID: 27670736
[TBL] [Abstract][Full Text] [Related]
19. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
20. IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia.
L'Abbate A; Cutrupi S; Rognetta M; Fabiano C; Craxi A
Clin Exp Immunol; 1993 Nov; 94(2):313-6. PubMed ID: 7693384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
